Batten Disease – neuronal ceroid lipofuscinoses (NCLs) – is a group of rare and fatal neurogenerative genetic disorders in young children whose symptoms were untreatable until Robert Wood Johnson Medical School and the Rutgers Center for Advanced Biotechnology and Medicine researchers Peter Lobel and David Sleat discovered the disease’s genetic cause in 1997. Their groundbreaking discovery and partnership with the Office for Research (OfR) Technology Transfer team and biopharmaceutical company BioMarin led to Brineura, the first life-extending treatment for young patients.